This clinical trial evaluates whether the Transportation for Cancer Care Navigation Tool (TRACT) can improve travel barriers among patients with solid tumors receiving radiation therapy. It is estimated that 20-30% patients with cancer experience travel-related barriers for cancer care. This is a particular problem for patients with radiation therapy as these patients frequently receive multiple treatment cycles, which often require daily treatment for multiple weeks or months. Addressing travel barriers has been a prerequisite for cancer care as travel barriers negatively influence cancer treatment adherence and cancer care outcomes, such as survival and quality of life. The TRACT program may help reduce travel barriers and therefore promote health equity among patients with solid tumors receiving radiation therapy.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06541158.
Locations matching your search criteria
United States
Georgia
Atlanta
Emory University Hospital MidtownStatus: Active
Contact: Jinbing Bai
Phone: 404-727-2466
Emory University Hospital/Winship Cancer InstituteStatus: Active
Contact: Jinbing Bai
Phone: 404-727-2466
PRIMARY OBJECTIVES:
I. To work collaboratively with a Community Advisory Board (CAB, e.g., patients, caregivers, clinicians, and social workers) to refine a theory-driven TRACT program for solid tumor patients receiving radiation therapy (RT) with travel barriers.
II. To evaluate the feasibility of the TRACT program for patients with solid tumors receiving RT with travel barriers.
III. To explore the efficacy of the TRACT program on RT adherence (canceling, delaying, missing, or terminating essential care) and patient-reported outcomes (PROs) (distress, financial toxicity, and quality of life [QOL]) compared to enhanced usual care (EUC, usual care + transportation awareness brief video with Patient Advocate Foundation [PAF] pamphlet).
OUTLINE:
STAGE I (CAB): Participants meet with the study research team to develop and refine the TRACT program.
STAGE II: Patients are randomized to 1 or 2 groups.
GROUP I: Patients receive the TRACT program consisting: of 1) Screening of travel barriers; 2) Awareness of transportation obstacles and resources using videos, 3) Assistance with transportation resource application and utilization, and 4) Alignment of community resources to navigate individualized transportation support by the trained travel navigator for 3 months.
GROUP II: Patients receive usual care and transportation awareness video with PAF pamphlet for 3 months.
After completion of study intervention, patients are followed up at 3 months.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationEmory University Hospital/Winship Cancer Institute
Principal InvestigatorJinbing Bai
